Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brii Biosciences Limited (DE:7SS)
FRANKFURT:7SS
RESEARCH TOOLSreports
Brii Biosciences Limited (7SS) Stock Price & Analysis
0 Followers
7SS Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.10 - €0.41
Previous Close€0.12
Volume0.00
Average Volume (3M)14.28K
Market Cap
€90.16M
Enterprise Value-€320.43M
Total Cash (Recent Filing)¥3.22B
Total Debt (Recent Filing)¥17.47M
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Aug 22, 2024EPS Estimate
-€0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding729,639,166
10 Day Avg. Volume428
30 Day Avg. Volume14,276
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
Brii Biosciences Limited News
PremiumCompany Announcements
Brii Biosciences Announces Board Composition
PremiumCompany Announcements
Brii Biosciences Shareholders Approve Key ResolutionsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.03% Mutual Funds
0.09% Other Institutional Investors
99.87% Public Companies and
Individual Investors
7SS FAQ
What was Brii Biosciences Limited’s price range in the past 12 months?
Brii Biosciences Limited lowest stock price was €0.10 and its highest was €0.41 in the past 12 months.
What is Brii Biosciences Limited’s market cap?
Currently, no data Available
When is Brii Biosciences Limited’s upcoming earnings report date?
Brii Biosciences Limited’s upcoming earnings report date is Aug 22, 2024 which is in 29 days.
How were Brii Biosciences Limited’s earnings last quarter?
Brii Biosciences Limited released its earnings results on Mar 22, 2024. The company reported €0.003 earnings per share for the quarter, beating the consensus estimate of -€0.068 by €0.071.
Is Brii Biosciences Limited overvalued?
According to Wall Street analysts Brii Biosciences Limited’s price is currently Overvalued.
Does Brii Biosciences Limited pay dividends?
Brii Biosciences Limited does not currently pay dividends.
What is Brii Biosciences Limited’s EPS estimate?
Brii Biosciences Limited’s EPS estimate is -€0.04.
How many shares outstanding does Brii Biosciences Limited have?
Brii Biosciences Limited has 729,989,750 shares outstanding.
What happened to Brii Biosciences Limited’s price movement after its last earnings report?
Brii Biosciences Limited reported an EPS of €0.003 in its last earnings report, beating expectations of -€0.068. Following the earnings report the stock price went down -8.333%.
Which hedge fund is a major shareholder of Brii Biosciences Limited?
Currently, no hedge funds are holding shares in DE:7SS
---
Brii Biosciences Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.27%
12-Months-Change
Fundamentals
Return on Equity
-5.54%
Trailing 12-Months
Asset Growth
-5.71%
Trailing 12-Months
Company Description
Brii Biosciences Limited
Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed towards developing advancing therapies for significant infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as the CNS diseases, which have significant public health burdens in China and worldwide.
---
7SS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 7SS
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-40.90%
reiterated a buy rating 2 months ago
Copying Roanna Ruiz's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -40.90% per trade.
---